Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN119,1119,18-0,58
Msft-0,42
Nokia6,6986,898-0,09
IBM0,90
Mercedes-Benz Group AG54,7854,8-1,56
PFE1,65
07.03.2026 0:38:30
Indexy online
AD Index online
select
AD Index online
 

  • 06.03.2026
William Demant Hldg (Copenhagen)
Závěr k 6.3.2026 Změna (%) Změna (DKK) Objem obchodů (DKK)
187,50 -0,42 -0,80 78 665 008
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 07.03.2026
Popis společnosti
Obecné informace
Název společnostiDemant A/S
TickerDEMANT
Kmenové akcie:Ordinary Shares
RICDEMANT.CO
ISINDK0060738599
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky31.12.2025
Počet zaměstnanců k 31.12.2025 26 704
Akcie v oběhu k 31.12.2025 210 898 609
MěnaDKK
Kontaktní informace
UliceKongebakken 9
MěstoSMOERUM
PSČ2765
ZeměDenmark
Kontatní osobaPeter Pudselykke
Funkce kontaktní osobyHead - Investor Relations
Telefon4 539 177 300
Fax4539277900
Kontatní telefon4 539 177 300

Business Summary: Demant A/S, formerly William Demant Holding A/S, is a Denmark-based company engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The Company operates globally, through more than 90 subsidiaries and associates worldwide.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Demant A/S revenues increased 2% to DKR22.97B. Net income before extraordinary items decreased 18% to DKR2.37B. Revenues reflect Hearing Care segment increase of 8% to DKR10.72B, Europe segment increase of 10% to DKR10.23B, Rest of the world segment increase of 5% to DKR679M. Net income was offset by Step-up gain on acquisition increase from DKR324M (income) to DKR82M (expense).
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical Appliance and Supplies Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSWireless Telecommunications Carriers (except Satellite)
NAICSAudio and Video Equipment Manufacturing
NAICSMedical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICSAll Other Miscellaneous Ambulatory Health Care Services
NAICSAll Other Support Services
NAICS2007Electromedical Apparatus Mfg
NAICS2007All Other Health & Personal Care Stores
NAICS2007All Oth Misc Ambulatory Health Care Services
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997All Other Health and Personal Care Stores
NAICS1997All Other Miscellaneous Ambulatory Health Care Services
SICSurgical Appliances And Supplies
SICElectromedical Equipment
SICRadiotelephone Communications
SICHousehold Audio/video Equipment
SICMedical And Hospital Equipment
SICHealth And Allied Services, Nec
SICBusiness Services, Nec



  • Poslední aktualizace: 07.03.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, Member of the Executive BoardSoeren Nielsen5401.04.201716.06.2015
Chief Financial Officer, Member of the Executive BoardRene Schneider5301.09.201501.09.2015
President - Diagnostics, Member of the Executive BoardAnne-Karen Hunt4801.11.202401.11.2024
President - Hearing Care, Member of the Executive BoardNiels Wagner5501.04.2022